Birdwatch Note
2024-03-31 19:34:16 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Novo Nordisk spent over $2B in R&D over half a decade to make develop Ozempic. https://en.wikipedia.org/wiki/Semaglutide https://www.macrotrends.net/stocks/charts/NVO/novo-nordisk/research-development-expenses
Written by 2215A9378C73FCF993B87E67792B9B7CDC6D03A93F82B60A14A061F6F8ED2652
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1773059500448133258
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1774520608384246241
- noteId - 1774520608384246241
- participantId -
- noteAuthorParticipantId - 2215A9378C73FCF993B87E67792B9B7CDC6D03A93F82B60A14A061F6F8ED2652 Participant Details
- createdAtMillis - 1711913656694
- tweetId - 1773059500448133258
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 1
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Novo Nordisk spent over $2B in R&D over half a decade to make develop Ozempic. https://en.wikipedia.org/wiki/Semaglutide https://www.macrotrends.net/stocks/charts/NVO/novo-nordisk/research-development-expenses
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2024-03-31 19:34:16 UTC (1711913656694) |
2024-04-01 00:30:09 UTC (1711931409293) |
CURRENTLY_RATED_HELPFUL | 2024-04-01 03:14:14 UTC (1711941254008) |
NEEDS_MORE_RATINGS | 2024-04-01 00:30:09 UTC (1711931409293) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
rated at | rated by | |
2024-03-31 21:28:42 -0500 | Rating Details | |
2024-03-31 20:54:12 -0500 | Rating Details | |
2024-03-31 20:53:49 -0500 | Rating Details | |
2024-03-31 20:40:56 -0500 | Rating Details | |
2024-03-31 20:04:09 -0500 | Rating Details | |
2024-03-31 19:19:07 -0500 | Rating Details | |
2024-03-31 18:54:53 -0500 | Rating Details | |
2024-03-31 18:49:17 -0500 | Rating Details | |
2024-03-31 18:17:09 -0500 | Rating Details | |
2024-03-31 18:09:05 -0500 | Rating Details | |
2024-03-31 18:04:34 -0500 | Rating Details | |
2024-03-31 17:55:11 -0500 | Rating Details | |
2024-03-31 17:51:22 -0500 | Rating Details | |
2024-03-31 17:31:20 -0500 | Rating Details | |
2024-03-31 17:18:19 -0500 | Rating Details | |
2024-03-31 16:36:09 -0500 | Rating Details | |
2024-03-31 16:30:07 -0500 | Rating Details | |
2024-03-31 16:20:42 -0500 | Rating Details | |
2024-03-31 16:18:10 -0500 | Rating Details | |
2024-03-31 16:07:06 -0500 | Rating Details | |
2024-03-31 15:55:16 -0500 | Rating Details | |
2024-03-31 15:53:45 -0500 | Rating Details | |
2024-03-31 15:51:52 -0500 | Rating Details | |
2024-03-31 15:42:44 -0500 | Rating Details | |
2024-03-31 15:35:39 -0500 | Rating Details | |
2024-03-31 14:59:57 -0500 | Rating Details | |
2024-03-31 14:55:29 -0500 | Rating Details | |
2024-03-31 14:51:58 -0500 | Rating Details | |
2024-03-31 14:45:39 -0500 | Rating Details | |
2024-03-31 14:42:53 -0500 | Rating Details | |
2024-03-31 14:42:14 -0500 | Rating Details | |
2024-04-01 18:05:46 -0500 | Rating Details | |
2024-04-01 13:51:15 -0500 | Rating Details | |
2024-04-01 13:42:34 -0500 | Rating Details | |
2024-04-01 11:43:38 -0500 | Rating Details | |
2024-04-01 10:57:49 -0500 | Rating Details | |
2024-04-01 10:49:33 -0500 | Rating Details | |
2024-04-01 10:23:35 -0500 | Rating Details | |
2024-04-01 07:39:45 -0500 | Rating Details | |
2024-04-01 06:50:22 -0500 | Rating Details | |
2024-04-01 06:47:04 -0500 | Rating Details | |
2024-04-01 06:46:16 -0500 | Rating Details | |
2024-04-01 06:26:18 -0500 | Rating Details | |
2024-04-01 06:12:57 -0500 | Rating Details | |
2024-04-01 05:12:09 -0500 | Rating Details | |
2024-04-01 02:07:27 -0500 | Rating Details | |
2024-04-01 00:35:10 -0500 | Rating Details | |
2024-04-01 00:00:39 -0500 | Rating Details | |
2024-03-31 22:25:37 -0500 | Rating Details | |
2024-03-31 22:14:46 -0500 | Rating Details | |
2024-03-31 22:12:43 -0500 | Rating Details | |
2024-03-31 22:02:24 -0500 | Rating Details | |
2024-03-31 21:55:07 -0500 | Rating Details | |
2024-03-31 21:46:20 -0500 | Rating Details | |
2024-03-31 20:53:36 -0500 | Rating Details | |
2024-03-31 20:36:17 -0500 | Rating Details | |
2024-03-31 20:32:46 -0500 | Rating Details | |
2024-03-31 20:27:05 -0500 | Rating Details | |
2024-03-31 19:59:07 -0500 | Rating Details | |
2024-03-31 19:54:20 -0500 | Rating Details | |
2024-03-31 19:35:19 -0500 | Rating Details | |
2024-03-31 19:26:32 -0500 | Rating Details | |
2024-03-31 19:22:07 -0500 | Rating Details | |
2024-03-31 19:06:40 -0500 | Rating Details | |
2024-03-31 18:41:58 -0500 | Rating Details | |
2024-03-31 18:40:40 -0500 | Rating Details | |
2024-03-31 18:07:46 -0500 | Rating Details | |
2024-03-31 17:54:01 -0500 | Rating Details | |
2024-03-31 17:34:45 -0500 | Rating Details | |
2024-03-31 17:32:10 -0500 | Rating Details | |
2024-03-31 17:29:01 -0500 | Rating Details | |
2024-03-31 16:26:20 -0500 | Rating Details | |
2024-03-31 16:24:51 -0500 | Rating Details | |
2024-03-31 16:19:45 -0500 | Rating Details | |
2024-03-31 15:42:10 -0500 | Rating Details | |
2024-03-31 15:40:56 -0500 | Rating Details | |
2024-03-31 15:39:49 -0500 | Rating Details | |
2024-03-31 15:30:07 -0500 | Rating Details | |
2024-03-31 15:25:44 -0500 | Rating Details | |
2024-03-31 15:03:52 -0500 | Rating Details | |
2024-03-31 14:51:54 -0500 | Rating Details | |
2024-03-31 14:37:55 -0500 | Rating Details | |
2024-04-02 12:03:06 -0500 | Rating Details | |
2024-04-02 11:40:53 -0500 | Rating Details | |
2024-04-02 08:47:44 -0500 | Rating Details | |
2024-04-02 07:06:52 -0500 | Rating Details | |
2024-04-05 01:51:01 -0500 | Rating Details | |
2024-04-17 14:09:36 -0500 | Rating Details | |
2024-04-02 17:51:01 -0500 | Rating Details | |
2024-04-02 12:39:14 -0500 | Rating Details | |
2024-04-02 00:54:21 -0500 | Rating Details | |
2024-04-01 14:07:20 -0500 | Rating Details | |
2024-04-01 13:38:13 -0500 | Rating Details | |
2024-04-01 13:01:13 -0500 | Rating Details | |
2024-04-01 12:15:21 -0500 | Rating Details | |
2024-04-01 08:49:39 -0500 | Rating Details | |
2024-04-01 08:32:05 -0500 | Rating Details | |
2024-04-01 08:27:39 -0500 | Rating Details | |
2024-04-01 07:15:28 -0500 | Rating Details | |
2024-04-01 05:48:06 -0500 | Rating Details | |
2024-04-01 04:17:06 -0500 | Rating Details | |
2024-04-01 01:00:18 -0500 | Rating Details | |
2024-04-01 00:02:38 -0500 | Rating Details | |
2024-03-31 23:30:32 -0500 | Rating Details | |
2024-03-31 22:50:47 -0500 | Rating Details | |
2024-03-31 22:25:05 -0500 | Rating Details | |
2024-03-31 21:54:50 -0500 | Rating Details | |
2024-03-31 21:43:51 -0500 | Rating Details | |
2024-04-23 05:37:10 -0500 | Rating Details | |
2024-04-25 05:06:32 -0500 | Rating Details | |
2024-06-12 08:03:51 -0500 | Rating Details |